![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Bbi Enzymes Sa (pty) Ltd Cape Town Za, based in United Kingdom, is a pharmaceutical company.
One of their significant offerings is Deoxyribonuclease, (Product codes: 041160, 041157, 041151 and 041150), supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-247 - Rev 01
This TSE Type CEP, issued on July 23, 2009, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.